Proton Pump Inhibitors Inhibit PHOSPHO1 Activity and Matrix Mineralisation In Vitro

Proton pump inhibitors (PPIs) have been associated with an increased risk of fragility fractures in pharmaco-epidemiological studies. The mechanism is unclear, but it has been speculated that by neutralising gastric acid, they may reduce intestinal calcium absorption, causing secondary hyperparathyr...

Descripción completa

Detalles Bibliográficos
Autores principales: Staines, Katherine A., Myers, Katherine, Little, Kirsty, Ralston, Stuart H., Farquharson, Colin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531085/
https://www.ncbi.nlm.nih.gov/pubmed/34213594
http://dx.doi.org/10.1007/s00223-021-00882-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531085/
https://www.ncbi.nlm.nih.gov/pubmed/34213594
http://dx.doi.org/10.1007/s00223-021-00882-9

Ejemplares similares